Search

everythinglearnresearchcommunity

for

Search:↓

HDR electronic brachytherapy effectively treats nonmelanoma skin cancer with good cosmetic results and minimal side effects.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Flutamide, a medication used for excessive hair growth, can cause severe liver damage in women.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

In Brazil in 2018, the most common skin issues were acne, photoaging, and nonmelanoma skin cancer, with treatments often including topical medications and sunscreen.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Taking spironolactone doesn't increase the chance of breast cancer coming back.

Chemotherapy causes hair loss in cancer patients by affecting both growing and resting hair.

Male pattern baldness might have evolved to help protect against prostate cancer by increasing UV radiation on the scalp.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

Anti-cancer drugs are diverse and hard to classify due to their different forms and actions.

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.

A prostate cancer drug can lower the levels of a protein that the coronavirus uses to enter lung cells.

CDK4/6 inhibitors generally maintain quality of life in metastatic breast cancer patients, except for some side effects like diarrhea and hair loss.

The British Association of Dermatologists celebrated 100 years by looking back at important research, including work on hair loss, skin condition impact, psoriasis treatment, and skin cancer rates.

Transforming skin disease treatment requires new strategies, better drug models, and patient-focused research.

Tamoxifen increases the risk of lasting hair loss after chemotherapy despite scalp cooling.

Platelet-rich fibrin may help reduce nonmelanoma skin cancer cell growth.

Metastatic cervical cancer can cause rare, severe Cushing's syndrome with high risk of death.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

No increased skin cancer risk was found in alopecia patients treated with photobiomodulation.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Patients with nonmelanoma skin cancers are most bothered by fear of progression, appearance concerns, and having cancer.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.